Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, J.H. | - |
dc.contributor.author | Hong, H.C. | - |
dc.contributor.author | Cho, M.J. | - |
dc.contributor.author | Kim, Y.J. | - |
dc.contributor.author | Choi, H.Y. | - |
dc.contributor.author | Eun, C.R. | - |
dc.contributor.author | Yang, S.J. | - |
dc.contributor.author | Yoo, H.J. | - |
dc.contributor.author | Kim, H.Y. | - |
dc.contributor.author | Seo, J.A. | - |
dc.contributor.author | Kim, S.G. | - |
dc.contributor.author | Choi, K.M. | - |
dc.contributor.author | Baik, S.H. | - |
dc.contributor.author | Choi, D.S. | - |
dc.contributor.author | Kim, N.H. | - |
dc.date.accessioned | 2021-09-07T04:27:00Z | - |
dc.date.available | 2021-09-07T04:27:00Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2012 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/110750 | - |
dc.description.abstract | Background: Aldosterone antagonists are reported to have beneficial effects on diabetic nephropathy by effective blocking of the renin-angiotensin-aldosterone system. We investigated the renoprotective effect of the selective aldosterone receptor blocker eplerenone, the angiotensin converting enzyme inhibitor lisinopril, and combined eplerenone and lisinopril treatment in type 2 diabetic rats. Methods: Animals were divided into six groups as follows: Otsuka Long-Evans Tokushima Fatty (OLETF) rat control, OLETF rats treated with a low dose of eplerenone (50 mg/kg/day), OLETF rats treated with a high dose of eplerenone (200 mg/kg/day), OLETF rats treated with lisinopril (10 mg/kg/day), OLETF rats treated with a combination of both drugs (eplerenone 200 mg/kg/day and lisinopril 10 mg/kg/day), and obese non-diabetic Long-Evans Tokushima Otsuka rats for 26 weeks. Results: Urinary albumin excretion was significantly lower in the lisinopril group, but not in the eplerenone group. Urinary albumin excretion was decreased in the combination group than in the lisinopril group. Glomerulosclerosis and renal expression of type I and type IV collagen, plasminogen activator inhibitor-1, transforming growth factor-β1, connective tissue growth factor, and fibronectin mRNA were markedly decreased in the lisinopril, eplerenone, and combination groups. Conclusion: Eplerenone and lisinopril combination showed additional benefits on type 2 diabetic nephropathy compared to monotherapy of each drug. © 2012 Korean Diabetes Association. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.title | Effect of eplerenone, a selective aldosterone blocker, on the development of diabetic nephropathy in type 2 diabetic rats | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Seo, J.A. | - |
dc.contributor.affiliatedAuthor | Kim, S.G. | - |
dc.contributor.affiliatedAuthor | Choi, K.M. | - |
dc.contributor.affiliatedAuthor | Baik, S.H. | - |
dc.contributor.affiliatedAuthor | Choi, D.S. | - |
dc.contributor.affiliatedAuthor | Kim, N.H. | - |
dc.identifier.doi | 10.4093/dmj.2012.36.2.128 | - |
dc.identifier.scopusid | 2-s2.0-84864619656 | - |
dc.identifier.bibliographicCitation | Diabetes and Metabolism Journal, v.36, no.2, pp.128 - 135 | - |
dc.relation.isPartOf | Diabetes and Metabolism Journal | - |
dc.citation.title | Diabetes and Metabolism Journal | - |
dc.citation.volume | 36 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 128 | - |
dc.citation.endPage | 135 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001654205 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Aldosterone receptor blocker | - |
dc.subject.keywordAuthor | Diabetic nephropathy | - |
dc.subject.keywordAuthor | Eplerenone | - |
dc.subject.keywordAuthor | Lisinopril | - |
dc.subject.keywordAuthor | Type 2 diabetic rats | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.